PharmAware Blog

GlaxoSmithKline has announced that it will make the chemical structures of 13 500 compounds with potential antimalarial activity freely available on scientific websites to encourage research into new drugs for malaria.

For full article, http://www.bmj.com/cgi/content/full/340/jan25_2/c465.

 This study looks at the 50 top medical centres in the US and their policies on ghostwriting. The authors found that only 26% of institutions have policy on ghostwriting.

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1000230